Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Payables: 2020-2024

Historic Payables for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $63.3 million.

  • Cellebrite DI's Payables rose 580.38% to $62.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.7 million, marking a year-over-year increase of 185.21%. This contributed to the annual value of $63.3 million for FY2024, which is 41.22% up from last year.
  • As of FY2024, Cellebrite DI's Payables stood at $63.3 million, which was up 41.22% from $44.8 million recorded in FY2023.
  • In the past 5 years, Cellebrite DI's Payables registered a high of $63.3 million during FY2024, and its lowest value of $44.8 million during FY2023.
  • Over the past 3 years, Cellebrite DI's median Payables value was $45.5 million (recorded in 2022), while the average stood at $51.2 million.
  • Its Payables has fluctuated over the past 5 years, first dropped by 15.90% in 2022, then surged by 41.22% in 2024.
  • Cellebrite DI's Payables (Yearly) stood at $49.1 million in 2020, then grew by 10.04% to $54.0 million in 2021, then declined by 15.90% to $45.5 million in 2022, then dropped by 1.34% to $44.8 million in 2023, then soared by 41.22% to $63.3 million in 2024.